List of works - Naoto T Ueno

2-Chlorodeoxyadenosine therapy for idiopathic hypereosinophilic syndrome ⬇️

scientific article published on August 1, 1997

A Prospective Study of Bone Tumor Response Assessment in Metastatic Breast Cancer ⬇️

scientific article published on October 24, 2012

A preclinical investigation of the saturation and dosimetry of 153Sm-DOTMP as a bone-seeking radiopharmaceutical ⬇️

scientific article published on March 28, 2012

Activation of Canonical BMP4-SMAD7 Signaling Suppresses Breast Cancer Metastasis

scientific article published on 15 January 2020

Addition of GM-CSF to trastuzumab stabilises disease in trastuzumab-resistant HER2+ metastatic breast cancer patients ⬇️

scientific article published on September 28, 2010

Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer ⬇️

scientific article published on 01 March 1998

Androgen receptor expression on circulating tumor cells in metastatic breast cancer.

scientific article published on 28 September 2017

Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer

scientific article published on 02 March 2019

Birinapant Enhances Gemcitabine's Anti-tumor Efficacy in Triple-Negative Breast Cancer by Inducing Intrinsic Pathway-Dependent Apoptosis

scientific article published on 15 December 2020

Cancer Response Criteria and Bone Metastases: RECIST 1.1, MDA and PERCIST ⬇️

scientific article published on June 28, 2010

Characterization of metastatic breast cancer patients with nondetectable circulating tumor cells ⬇️

scientific article published on November 28, 2010

Chemosensitization of HER-2/neu-overexpressing human breast cancer cells to paclitaxel (Taxol) by adenovirus type 5 E1A ⬇️

scientific article published on August 18, 1997

Chromosome 17 polysomy in circulating tumor cells in patients with metastatic breast cancer: a case series ⬇️

scientific article published on 06 January 2011

Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M. D. Anderson Cancer Center ⬇️

scientific article published on January 1, 1997

Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC

scientific article published on 18 January 2022

Comparison of molecular profile in triple-negative inflammatory and non-inflammatory breast cancer not of mesenchymal stem-like subtype

scientific article published on 18 September 2019

Cooperative Effect of Oncogenic MET and PIK3CA in an HGF-Dominant Environment in Breast Cancer

scientific article published on 05 December 2018

Correction to: Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer

scientific article published on 01 July 2019

Ensemble of nucleic acid absolute quantitation modules for copy number variation detection and RNA profiling

scientific article published on 04 April 2022

FDG-PET/CT Compared with Conventional Imaging in the Detection of Distant Metastases of Primary Breast Cancer ⬇️

scientific article published on July 17, 2011

Fuel, electricity, ER and HER2—a hybrid-car model of breast cancer ⬇️

scientific article published on June 5, 2012

Future directions of bone-targeted therapy for metastatic breast cancer ⬇️

scientific article published on August 31, 2010

Gemcitabine Overcomes Erlotinib Resistance in EGFR-Overexpressing Cancer Cells through Downregulation of Akt ⬇️

scientific article published on August 7, 2011

Growth suppression of low HER-2/neu-expressing breast cancer cell line MDA-MB-435 by tyrosine kinase inhibitor emodin ⬇️

scientific article published on May 1, 1996

High-Dose Chemotherapy With Autologous Hematopoietic Stem-Cell Transplantation in Metastatic Breast Cancer: Overview of Six Randomized Trials ⬇️

scientific article published on July 18, 2011

Identification of triple-negative breast cancer cell lines classified under the same molecular subtype using different molecular characterization techniques: Implications for translational research

scientific article published on 30 April 2020

Impact of change in body mass index during neoadjuvant chemotherapy and survival among breast cancer subtypes

scientific article published on 18 June 2018

Information Sharing and Case Conference Among the Multidisciplinary Team Improve Patients’ Perceptions of Care ⬇️

scientific article published on October 26, 2011

Initial Staging Impact of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Locally Advanced Breast Cancer ⬇️

scientific article published on May 31, 2011

JNK Signaling in Stem Cell Self-Renewal and Differentiation

scientific article published on 09 April 2020

Loss of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Metastatic Sites of HER2-Overexpressing Primary Breast Tumors ⬇️

scientific article published on November 28, 2011

Metastasis in the Breast Mimicking Inflammatory Breast Cancer ⬇️

scientific article published on June 25, 2012

NDRG1 Expression Is an Independent Prognostic Factor in Inflammatory Breast Cancer

scientific article published on 10 December 2020

Novel mechanism of reduced proliferation in ovarian clear cell carcinoma cells: Cytoplasmic sequestration of CDK2 by p27 ⬇️

scientific article published on June 8, 2011

Phase II study of Radium-223 dichloride combined with hormonal therapy for hormone receptor-positive, bone-dominant metastatic breast cancer

scientific article published on 18 December 2019

Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome ⬇️

scientific article published on June 28, 2011

Poor Response to Neoadjuvant Chemotherapy Correlates with Mast Cell Infiltration in Inflammatory Breast Cancer

scientific article published on 01 May 2019

Poor prognosis of patients with triple-negative breast cancer can be stratified by RANK and RANKL dual expression

scientific article published on 17 April 2017

Primary malignant teratoma of the thyroid gland: Report and discussion of two cases ⬇️

scientific article published on 01 October 1998

Prognostic Impact of Phosphorylated HER-2 in HER-2+ Primary Breast Cancer ⬇️

scientific article published on June 28, 2011

Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC

scientific article published on 18 May 2020

Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype

scientific article published in PLoS ONE

Retrospective analysis of antitumor effects of zoledronic acid in breast cancer patients with bone‐only metastases ⬇️

scientific article published on 02 December 2011

ST8SIA1 Regulates Tumor Growth and Metastasis in TNBC by Activating the FAK-AKT-mTOR Signaling Pathway

scientific article published on 20 September 2018

Targeting EGFR in Triple Negative Breast Cancer ⬇️

scientific article published on May 28, 2011

Targeting Signaling Pathways in Inflammatory Breast Cancer

scientific article published on 01 September 2020

The Role of 18F-FDG-Positron Emission Tomography/Computed Tomography in Staging Primary Breast Cancer ⬇️

scientific article published on June 22, 2010

The efficacy of first-line chemotherapy in endocrine-resistant hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer

scientific article published on 27 July 2020

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies ⬇️

scientific article published on 01 August 1998

Treatment Outcome and Prognostic Factors for Patients with Bone-Only Metastases of Breast Cancer: A Single-Institution Retrospective Analysis ⬇️

scientific article published on January 25, 2011

Use of Wearable Activity Tracker in Patients With Cancer Undergoing Chemotherapy: Toward Evaluating Risk of Unplanned Health Care Encounters